an apocarotenoid isolated from Bixa orellana L., sensitizes human melanoma cells to dacarbazine-induced apoptosis through ROS-mediated cytotoxicity. Food and Chemical Toxicology, Elsevier, 2019, 125, pp.ABSTRACT Cutaneous melanoma has a high capacity to metastasize and significant resistance to conventional therapeutic protocols, which makes its treatment difficult. The combination of conventional drugs with cytostatic molecules of low toxicity has been shown to be an interesting alternative for sensitization of tumor cells to chemotherapy. In this study, we evaluated the effect of bixin, an abundant apocarotenoid present in Bixa orellana, on the sensitization of human melanoma cells (A2058) to dacarbazine treatment, an anticancer agent clinically used for the therapy of metastatic melanoma. UPLC-DAD-MS/MS analyses of bioactive extracts from B. orellana seeds led to the identification of two new apocarotenoids: 6,8'-diapocarotene-6,8'-dioic acid and 6,7'-diapocarotene-6,7'-dioic acid. After being identified as its major compound, bixin (Z-bixin) was evaluated on A2058 cells expressing the oncogenic BRAF VE600 mutation and resistant to dacarbazine treatment. Bixin promoted growth inhibition, reduced cell migration, induced apoptosis and cell cycle arrest in the G2/M phase. When associated with dacarbazine, bixin restored the sensitivity of A2058 cells to chemotherapy, enhancing its antiproliferative, anti-migratory and pro-apoptotic effects.
Introduction
Although it has a low incidence, melanoma is responsible for about 80% of skin cancer-associated mortality (MacKie et al., 2009 ). It has a high propensity to metastasize and is poorly responsive to most of the conventional therapies. In general, metastatic melanoma presents a dismal prognosis, with a five-year overall survival rate of only 15% and a median survival of less than eight months with treatment (Chakraborty et al., 2013; Locatelli et al., 2013) .
In recent years, limited progress has been achieved in the treatment of metastatic melanoma through immunotherapy and target therapy (Flaherty and McArthur, 2010; Sosman and Puzanov, 2006) . In 2011, the Food and Drug Administration (FDA) approved vemurafenib (BRAF inhibitor) and ipilimumab (monoclonal antibody) for clinical trials in patients with metastatic melanoma. Melanoma therapy may also include the use of alkylating agents (e.g., dacarbazine, temozolomide), platinum derivatives (e.g., cisplatin, carboplatin), vinca alkaloids (e.g., vindesine, vinblastine) and cytokines (e.g., IFN-α, IL-2) (Bhatia et al., 2009; Chapman et al., 2011; Jin et al., 2018; Locatelli et al., 2013) . However, melanoma cells display multidrug resistance (MDR) mechanisms, which requires the use of higher doses to ensure a satisfactory pharmacological response. Unsuccessful treatments are often attributed to alterations in drug metabolism, efflux pump expression, apoptosis evasion mechanisms and mutations in specific therapeutic targets (Tentori et al., 2013) .
To improve therapeutic response, several combinations of anticancer drugs with different mechanisms of action have been studied (Jin et al., 2018) . Many combinatorial treatments tested in melanoma have associated immunologic agents (e.g., IFN-α, IL-2), hormones (e.g., tamoxifen) and target therapy drugs (e.g., vemurafenib) with dacarbazine, an alkylating agent considered as a single drug reference for the management of advanced melanoma. Nevertheless, the toxicity of these combinatorial treatments has been a limiting factor and no survival benefit has been demonstrated in comparison to monotherapy (Garbe et al., 2008; Mouawad et al., 2010) .
A variety of natural products has been reported for cancer therapy, acting not only as chemotherapeutic or chemopreventive agents but also by enhancing the effectiveness of conventional chemotherapy (Vinod et al., 2013) . Natural molecules sensitize tumor cells to chemotherapy by increasing the residence time of anticancer drugs in the cell, disrupting the cellular cytoskeleton, promoting DNA damage, inducing apoptosis, and/or regulating the expression of altered molecular targets (de Oliveira Júnior et al., 2018; Juin et al., 2018) . In addition, natural products generally show a better tolerance profile compared to conventional therapy, have lower toxicity and promote fewer side effects.
Bixa orellana L. is a Brazilian medicinal plant, popularly known as "urucum" and "colorau" (in Brazil), "achiote" (in Mexico), and "annatto" (in the USA). B. orellana has economic importance mainly due to its seeds, which provide a red dye widely used in food products, textile, pharmaceutical and cosmetic industries. In fact, about 70% of all natural coloring agents consumed worldwide are derived from annatto. In traditional medicine, its seeds are commonly used to treat diabetes, diarrhea, hepatitis and dyslipidemia. Previous pharmacological investigations showed that B. orellana seeds have antimicrobial, antiinflammatory, antioxidant, hypoglycemic and cytotoxic effects (Shahid-ul-Islam et al., 2016; Vilar et al., 2014) . The therapeutic properties and industrial applications of annatto seeds are directly related to the carotenoid content, especially bixin, the major apocarotenoid of this species (Priya et al., 2017; Rivera-Madrid et al., 2016) . In in vitro studies, bixin exhibited anticancer activity against HL60 (leukemia), B16 (melanoma), U20S (osteosarcoma), PC3 (prostate), HCT-116 (colon), MCF-7 (breast), DRO (anaplastic thyroid) and BHP-16 (papillary thyroid) cell lines. Bixin inhibited the proliferation of tumor cells in a concentration-dependent manner, through apoptosis induction and cell cycle arrest (Anantharaman et al., 2016; Santos et al., 2016; Tibodeau et al., 2010) . Interestingly, this metabolite has shown low toxicity in animal models (Agner et al., 2004; Bautista et al., 2004; Paumgartten et al., 2002; Stohs, 2014) , and it is therefore considered as a good candidate for sensitizing tumor cells.
In this present report, we described additional outcomes on the molecular mechanisms involved in the bixin pro-apoptotic effect and assessed its ability to sensitize melanoma cells to dacarbazine. All experiments were performed using the highly invasive A2058 human melanoma cell line, expressing the V600E BRAF oncogenic mutation, and resistant to dacarbazine therapy.
Materials and Methods

Plant material
Seeds of Bixa orellana were collected in Missão Velha (Coordinates: S 07°14'59", W 39°08'35"), State of Ceará, Brazil, in August 2017. Botanical identification was performed by comparison with a voucher specimen previously deposited at the Herbário Vale do São Francisco of the Universidade Federal do Vale do São Francisco (n° 16750). Once collected, botanical material was dried in an oven (40 °C) with air circulation, for 72 hours. All procedures for access to genetic patrimony and associated traditional knowledge were carried out and the project was registered in SisGen (Register #A45AFE5).
Extraction
Dried seeds (46 g) were submitted to sequential maceration using hexane (2.0 L), chloroform (2.0 L), ethyl acetate (2.0 L) and methanol (2.0 L) in increasing polarity order.
Two hours were designed for each extraction solvent, employing constant stirring (1000 rpm) at 50 °C. Extractive solutions were filtrated and concentrated on a rotatory evaporator at a maximum temperature of 50 °C, resulting in hexane (Hex-Bo, 4.68 g), chloroform (CHCl 3 -Bo, 1.88 g), ethyl acetate (EtOAc-Bo, 0.045 g) and methanol (MeOH-Bo, 0.22 g) extracts. All extracts were stored at -20 °C until chemical analysis and cell viability assay.
UPLC-DAD-MS/MS analysis
Analyses were carried out using an UHPLC system "Acquity UPLC H-class" (Waters, Milford, USA) coupled to a photodiode array (Waters 2996) and a high resolution mass spectrometer "XEVO G2S Q-TOF" equipped with an electrospray ionization source (Waters, Manchester, England). The UHPLC system was formed by a quaternary pump (Quaternary Solvent Manager, Waters) and an automatic injector (Sample Manager-FTN, Waters) equipped with a 10 μL injection loop. 5 μL of the samples were injected in a column "Acquity UPLC BEH C18" (Waters) (2.1 × 50 mm, 1.7 μm), and the products were eluted at a flow rate of 300 μL.min -1 using a gradient composed of solvents A (water/formic acid 100/0.001 (v:v)) and B (methanol/ formic acid 100/0.001 (v:v)), according to the following procedure: 0-1 min, 10% B; 1-2.5 min 10%-50% B ; 2.5-7 min 50% B; 7-10 min 50-30% B; 10-12 min, adjusted for the acquisition on a 250-800 nm interval in UV mode, with 5 spectra.s -1 and 1.2 nm of resolution. The analyses were performed in positive ionization mode with MSE function in a centroid mode. The MS parameters was applied in the ESI source for the two ionization mode were: source temperature 120 °C, desolvation temperature 500 °C, gas flowrate of the cone 50 L.h -1 , desolvation gas flow-rate 800 L.h -1 , capillary voltage 3.0 kV, sampling cone 130 V and source compensation 80 V. The instrument was adjusted for the acquisition on a 250-1300 m/z interval, with a scan time of 0.15 s. The mass spectrometer was calibrated before analysis using 0.5 mM sodium formate solution, and Leucine Enkephalin (M = 555.62 Da,1 ng. μL -1 ) was used as a lock-mass.
Isolation and characterization of bixin
After extraction, hexane extract showed a red precipitate. The supernatant was separated and the precipitate was washed successively in methanol, leading to isolation of bixin (1.15 g). The chemical characterization and purity of the sample were determined by UPLC-DAD-MS/MS analysis, as described in the previous topic. To ensure complete structural elucidation, 1 H and 13 C NMR experiments were performed on a JEOL JNM-LA400 spectrometer (Croissy-sur-Seine, France) operating at 400 MHz for 1 H experiment, 100 MHz for 13 C experiment. NMR spectra were obtained in deuterated DMSO (DMSO-d 6 ), using tetramethylsilane as an internal standard, with chemical shifts expressed in ppm (δ) and coupling constants (J) in Hz. Proton-coupling patterns were described as singlet (s), doublet (d), triplet (t), or multiplet (m).
Cell line and culture conditions
A2058 (ATCC ® CRL-11147 TM , LGC ATCC Standards, France) is a melanoma cell line obtained from metastatic cells removed from lymph nodes of a 43-year-old caucasian patient. Due to its highly invasive, metastatic and chemoresistance potentials related to V600E mutation in BRAF and mutations in PTEN and P53 genes, A2058 provides a clinically relevant model for evaluation not only of new anti-melanoma molecules, but also of new chemosensitizer agents, allowing the assessment of combined therapy (Dankort et al., 2009; Juin et al., 2018) . Cells were grown in 75 cm² flasks using DMEM (Dutscher, France) supplemented with 10% FCS (Dutscher, France) and 1% penicillin-streptomycin (1000 U.ml -1 and 100 µg.ml -1 , respectively) (Dutscher, France), at 37 °C in a 5% CO 2 humidified atmosphere.
Cell viability assay
The antiproliferative activity of extracts (Hex-Bo, CHCl 3 -Bo, EtOAc-Bo and MeOH-Bo) and bixin was determined using the MTT (Sigma-Aldrich ® , France) assay (Juin et al., 2018; Mosmann, 1983) . Cells (2 x 10 3 /well) were grown in 96-well plates with extracts (100 µg.ml -1 ) or increasing concentrations of bixin (0.1-100 µM). Cells were also exposed to varying concentrations of vemurafenib (0.1-100 µM) and dacarbazine (0.1-100 µM), alone or combined to bixin (0.1-100 µM) to assess its sensitizing effect. After 72h of treatment, 20 µl of a MTT solution (5 g.L -1 ) was added to each well and microplates were again incubated for 4h. Subsequently, the cell culture medium was removed and formazan crystals were dissolved in 100 µl DMSO. Absorbance was read at 550 nm using FLUOstar Omega microplate reader (BMG Labtech, France) and then converted into cell growth inhibition (GI%). Cellular morphology was observed after treatments under inverted phase contrast microscope (Nikon, Eclipse, France). IC 50 was determined by nonlinear regression analysis using Prism 6.0 (GraphPad Software).
Cell migration assay
Cells (2 x 10 4 /well) were incubated and grown to 90% confluence in 24-well plates.
Cell monolayers were scratched with a sterile plastic tip, washed with PBS and incubated in a new cell culture medium containing bixin (50 and 100 µM), dacarbazine (50 and 100 µM) or combined treatment, for 24h. Cell migration was microscopically (100x) monitored at 0 and 24h (Cisilotto et al., 2018) . Results were expressed as percentage of cell migration calculated by measuring the cell surface using ImageJ software.
Apoptosis analysis 2.8.1. Annexin V-Cy3 and 6-CFDA detection assay
Apoptosis was evaluated by using double staining with annexin V-Cy3 (red) and 6carboxyfluorescein diacetate (6-CFDA, green) (Sigma-Aldrich ® , France). Cells (5 x 10 3 /well) were incubated in culture conditions for 24h, and then treated with bixin (50 and 100 µM), dacarbazine (50 µM) or both (bixin 50 µM + dacarbazine 50 µM) for 72h. Cells were further washed with PBS, suspended in binding buffer and stained with Annexin V and 6-CFDA solution for 10 min, according to manufacturer's recommendations. DAPI solution was also added to the wells for DNA labelling of necrotic cells (Juin et al., 2018) . Cells treated with Staurosporine 1 µM for 4h were used as a positive control. Finally, cells were observed under fluorescent microscope (ZEISS Axion Observer, France).
Caspase-3 colorimetric assay
Caspase-3 activity was determined using a colorimetric assay (CASP3C kit, Sigma-Aldrich ® , France) based on the hydrolysis of the peptide substrate acetyl-Asp-Glu-Val-Asp pnitroanilide (Ac-DEVD-pNA), resulting in the release of p-nitroanilide (pNA) (Juin et al., 2018) . Cell suspension (2.5 ml at 5 x 10 5 cell.ml -1 ) was added to 75 cm 2 flasks containing 12.5 ml of cell culture medium (control group), bixin (50 µM), dacarbazine (50 µM) or combined drugs (bixin 50 µM + dacarbazine 50 µM) solubilized in cell culture medium. After 72h of treatment, cells were washed with PBS, lysed with lysis buffer, and caspase-3 activity was measured according to manufacturer's protocol.
Results were expressed as µmol pNA/min/ml. Cells treated with Staurosporine 1 µM for 4h were used as a positive control.
2.9. Oxidative stress analysis
Determination of ROS levels
Fluorescence microscopy imaging was used to investigate qualitative ROS generation in A2058 cells. Cells (5 x 10 3 /well) were incubated in culture conditions for 24h, and then exposed to bixin (50 µM 
Determination of MDA levels
Lipid peroxidation was determined by the reaction of malondialdehyde (MDA), an important marker for oxidative stress (Grotto et al., 2009) , with thiobarbituric acid (TBA) to form a colorimetric product (532 nm), proportional to the MDA present (Lipid Peroxidation MDA assay kit, Sigma-Aldrich ® , France). Cells (2.5 ml at 5 x 10 5 cell.ml -1 ) were grown in 75 cm 2 flasks to adhere for 24h. Then, cells were treated with bixin (50 µM), dacarbazine (50 µM) or combined drugs for 24h. After treatments, cells were washed and suspended in PBS.
Cell suspensions were diluted in PBS to obtain standardized concentrations of 1 x 10 6 cell.ml -1 for all groups. Subsequently, cells were lysed for MDA extraction and quantification according to manufacturer's recommendations.
Cell cycle analysis
A2058 cells were grown in control culture medium or treated with bixin 50 µM, dacarbazine 50 µM or combined therapy (dacarbazine + bixin) for 72h before being stained for 30 min at 37°C in PBS containing propidium iodide (PI 100 µg.ml -1 ), Rnase A (100 µg.ml -1 ) and 0.1% Triton X-100 (ThermoFisher Scientific, France). Cells were analyzed using a 
Statistical analysis
Data were expressed as mean ± SEM from three independent experiments. Unpaired Student's t and one-way ANOVA followed by Tukey's multiple comparison tests were performed according to the case (statistical significance when p<0.05), using Prism 6.0 (GraphPad software).
Results and discussion
Chemical composition of bioactive B. orellana extracts
Initially, the antiproliferative effect of all extracts was determined using the MTT assay. Hex-Bo, CHCl 3 -Bo and EtOAc-Bo presented high antiproliferative activity at 100 µg.ml -1 (Table 1) . MeOH-Bo was considered inactive against A2058 cells. Subsequently, the chemical characterization of bioactive extracts was performed by UPLC-DAD-MS/MS analysis. Results are expressed as mean ± SEM from at least three independent experiments.
UPLC-DAD has provide a chromatogram containing thirteen major peaks (Fig. 1) .
Among the identified compounds, Z-bixin (8) was the major chemical constituent in all extracts, in agreement with previous reports (Shahid-ul-Islam et al., 2016; Vilar et al., 2014) .
Bixin derivatives (norbixin and methyl-bixin) have also been identified (Jondiko and Pattenden, 1989) . In fact, bixin is the main apocarotenoid detected in B. orellana seeds, and the presence of its derivatives and isomers has been exhaustively reported in the literature, as well as their chromatographic profiles, which allowed us to determine them unambiguously in the analyzed extracts (Mercadante et al., 1997; Rehbein et al., 2007; Tocchini and Mercadante, 2001 ). Other compounds already described for this plant were also identified, such as geranylgeraniol (9), δ-tocotrienol (12), γ-tocotrienol (13) and eicosatrienoic acid (4) (Jondiko and Pattenden, 1989) . Moreover, we also manage to identify two compounds previously undescribed in B. orellana: naringenin (1) and β-12'-apo-carotenoic acid (11). To date, only three flavonoids have been reported for this species (leucocyanidin, luteolin and apigenin) (Chisté et al., 2011; Shahid-ul-Islam et al., 2016) . In addition to contribute to its chemical knowledge, the identification of the flavonoid naringenin demonstrates that our analytical method may be employed for the simultaneous analysis of carotenoids and phenolic compounds in B. orellana extracts (Figs. 1, 2 and 3 , Table 2 ). Interestingly, UPLC-DAD-MS/MS analysis also showed the presence of two unpublished compounds. Compounds 2 and 5 presented a characteristic UV absorption profile for apocarotenoids, with λ max at around 420, 445 and 475 nm ( of 2 and 5 were proposed after fragmentation study (Fig. 4) . All fragments present experimental mass consistent with theoretical values. In addition, some analogues of these molecules have been described in B. orellana extracts, suggesting that 2 and 5 can occur from known biosynthetic pathways (Mercadante et al., 1997; Rivera-Madrid et al., 2016) . All these data led to the identification for 2 and 5 as the original following structures: 6,8'diapocarotene-6,8'-dioic and 6,7'-diapocarotene-6,7'-dioic acids, respectively. 1952, 337.1797, 319.1690, 309.1848, 291.1743, 277.1584, 255.1379, 225.1275, 209.1327, 157.1011, 145 2105, 363.1952, 345.1850, 335.2004, 317.1900,289, 1954 282.1609, 209.1324, 157.1011, 145 2103, 363.1950, 345.1840, 335.1996, 317.1903, 289.1942, 282.1600, 209.1322, 157.1010, 145 2581, 233.2265, 217.1953, 191.1781, 177.1638, 163.1489, 149.1310, 135.1173, 123.1163, 109 2513, 297.1849, 268.2185, 243.1380, 225.1275, 199 
Purification and characterization of bixin
Analytical UPLC analysis at 460 nm showed 91% purity for the bixin isomer isolated from the Hex-Bo. Peak at 20.95 min showed λ max at 430, 461 and 490 nm, with III/II band ratio of 33%, in accordance with previous studies (Chisté et al., 2011; Rios et al., 2007 Rios et al., , 2005 (Fig. 5 ), all consistent with literature data (Chisté et al., 2011; Rehbein et al., 2007) .
NMR experiments were performed in order to confirm the putative structure. In the olefinic region, 1 H NMR spectra showed signals at δ H 7.88 ( (Rehbein et al., 2007) . The correlations observed in the 1 H-1 H COSY spectrum confirm the unequivocal assignment of the signals H-7/H-8 and H-7'/H-8' (Fig. 5 ). H-8', neighboring the methyl ester group, is slightly more deshielded than H-8 neighboring the acid function.
Previous chemical studies have also shown that the 9'-Z-bixin isomer is the most abundant in annatto seeds (Raddatz-Mota et al., 2017; Rivera-Madrid et al., 2016; Rodrigues et al., 2014; Tibodeau et al., 2010; Vilar et al., 2014) , corroborating our results. 
Exposure to bixin inhibits proliferation and migration of A2058 cells
The intrinsic antiproliferative effect of bixin was determined by the MTT assay. Bixin promoted concentration-dependent cell growth inhibition, whose IC 50 was determined as 40 μM (Fig. 6 ). In the cell migration assay, exposure to bixin (50 and 100 µM) suppressed cell migration into the zone free of cells (Fig. 6B) . The migration rate decreased approximately in 55 and 72%, respectively, compared to the control group. These results suggest that bixin inhibits both proliferation and cell mobility. 
Bixin potentiates antiproliferative and antimigratory activities of dacarbazine
To assess the capacity of bixin to potentiate the antiproliferative effect of marketavailable anticancer agents, A2058 cells were treated for 72h with bixin, vemurafenib and dacarbazine. Combined treatments were applied in order to compare them to the respective monotherapy. Vemurafenib is a BRAF inhibitor widely used in the treatment of metastatic melanoma, whereas dacarbazine is an anticancer drug commonly used in combination with other chemotherapeutic agents (e.g. vemurafenib). As shown in Table 3 , A2058 cells were sensitive to vemurafenib (IC 50 = 6.96 µM), but resistant to dacarbazine therapy (IC 50 > 100 µM). Bixin was not able to potentiate the antiproliferative effect of vemurafenib ( Fig. 7) .
However, melanoma cells were sensitive to dacarbazine when combined to bixin, exhibiting IC 50 = 31.85 µM. Compared to the monotherapy, combined treatment induced a significant reduction in cell density (Fig. 7D ). Control A2058 cells showed a regular epithelial morphology and became sub-confluent in 72h, while treated cells exhibited cell shrinkage and appearance of apoptotic cells. Although A2058 cells have been shown to be resistant to dacarbazine therapy in the MTT assay, a significant reduction in cell migration was observed after 24h treatment with dacarbazine 50 and 100 μM. In addition, combined treatment (dacarbazine + bixin) presented a more intense pharmacological response when compared to monotherapy, suggesting that bixin also enhances the antimigratory potential of dacarbazine (Fig. 8) . 
Bixin enhances pro-apoptotic effect of dacarbazine
The pro-apoptotic effect of bixin and combined therapy was determined by double fluorescence staining with Annexin V and 6-CFDA, and by measuring the caspase-3 activity.
6-CFDA is used to measure cell viability, while Annexin V is a classic marker of phosphatidylserine externalization, a typical phenomenon for apoptotic cells. In this sense, living cells will only stain with 6-CFDA (green), cells in early apoptosis will stain both with Annexin V (red) and 6-CFDA, and cells in late apoptosis will stain with Annexin V and DAPI (blue). As shown in Fig. 9 , bixin 50 µM increased the number of Annexin V and 6-CFDA double-stained cells, and Annexin V and DAPI stained cells, compared to control, suggesting that bixin presents significant pro-apoptotic activity. Dacarbazine 50 µM treatment also increased the number of cells in early apoptosis, but its pro-apoptotic effect was significantly improved when associated with bixin ( Fig. 9A) . Moreover, caspase-3 activity was significantly higher (p<0.05) in cells treated with combined therapy compared to treatments with dacarbazine or bixin (Fig. 9B ). Caspase-3 is one of the most important proapoptotic enzymes, which can be activated by both intrinsic (mitochondrial) and extrinsic (death ligand) apoptosis pathways. 
Bixin increases oxidative stress in combined treatment with dacarbazine
Although carotenoids are widely known for their antioxidant potential, a dual anti/prooxidant activity can also be observed for the same molecules. In fact, carotenoids exhibit high reactivity due to their conjugated double bonds system, which allows them to be readily oxidized by reactive oxygen species (ROS). In regular or high amounts of ROS, they are rapidly autoxidized and exhibit an expressive pro-oxidant activity. Pro-oxidant effects have also been reported when high concentrations of carotenoids were used. In cancer cells, these effects may induce oxidative damage to DNA, cell membrane and proteins involved in cell survival, inhibiting tumor growth (Eghbaliferiz and Iranshahi, 2016; Nagao, 2004; Ribeiro et al., 2018) . As previously reported, bixin has anti and pro-oxidant potential based on the tested concentrations and other biochemical factors (Anantharaman et al., 2016; Mohan et al., 2018; Tay-agbozo et al., 2018) . The pharmacological activities of bixin have been demonstrated mostly on carcinogenesis and lipid peroxidation (Anantharaman et al., 2016; Santos et al., 2016) , but the involvement of its pro-oxidant effect in sensitizing tumor cells to chemotherapy has not been properly explored so far.
In this study, we investigated ROS and MDA levels in A2058 cells treated with bixin, dacarbazine and combined drugs. ROS generation was assessed 24h after treatments.
Fluorescent micrographs of stained cells suggested that bixin 50 µM and dacarbazine 50 µM elevated ROS intensity compared to control cells. In addition, combined therapy (bixin + dacarbazine) exhibited higher ROS intensity than control and monotherapy conditions (Fig.   10A ). Quantitative measurement of ROS level corroborated this result (Fig. 10B ). ROS production was significantly increased (p<0.05) in cells treated with combined therapy compared to monotherapies. Similarly, combined therapy also increased MDA production compared to treatment with dacarbazine or bixin, suggesting cell membrane damage possibly caused by increased ROS production ( Fig. 10C ). Possible damage to the cell membrane could facilitate the entry of dacarbazine into the cell, justifying the enhancement of its pro-apoptotic effect during combined therapy. bixin and dacarbazine groups), according to ANOVA one-way followed by Tukey's post-test.
Cell cycle analysis
Evaluation of cell cycle progression by flow cytometry revealed an increase in G2/M cell population after treatment with bixin 50 µM (Fig. 11 ). Anantharaman et al. (2016) has also demonstrated that bixin induces cell cycle arrest in the G2/M phase in experiments performed with B16 murine melanoma cells. In addition, our results also showed an increase in sub-G1 (apoptotic) cells after exposure to dacarbazine 50 µM and combined therapy (dacarbazine + bixin) compared to untreated cells. However, no significant change between these groups was observed, indicating that bixin exerts no significant contribution on dacarbazine-induced cell cycle arrest. 
Conclusion
B. orellana bioactive extracts were chemically characterized by UPLC-DAD-MS/MS analysis, which led to the identification of two new apocarotenoids (compounds 2 and 5).
After being detected as a major component, 9'-Z-bixin was purified and tested in viability and cell migration models. In vitro assays showed that bixin restored the sensitivity of A2058 melanoma cells to dacarbazine and enhanced its antimigratory activity. Different experiments also indicated that this apocarotenoid potentiated the pro-apoptotic effect of dacarbazine by increasing oxidative stress. Further investigations will be mandatory to confirm the pharmacological interest of bixin to potentiate the antitumour activity of antimelanoma drugs in in vivo models.
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